GB1253500A - Method of contraception - Google Patents
Method of contraceptionInfo
- Publication number
- GB1253500A GB1253500A GB0714/71A GB171471A GB1253500A GB 1253500 A GB1253500 A GB 1253500A GB 0714/71 A GB0714/71 A GB 0714/71A GB 171471 A GB171471 A GB 171471A GB 1253500 A GB1253500 A GB 1253500A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gestagen
- esters
- action
- dose
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000583 progesterone congener Substances 0.000 abstract 6
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 abstract 1
- XURCMZMFZXXQDJ-UKNJCJGYSA-N Gestonorone caproate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 XURCMZMFZXXQDJ-UKNJCJGYSA-N 0.000 abstract 1
- 210000003756 cervix mucus Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 230000003152 gestagenic effect Effects 0.000 abstract 1
- 230000002267 hypothalamic effect Effects 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- FRQMUZJSZHZSGN-HBNHAYAOSA-N medroxyprogesterone Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FRQMUZJSZHZSGN-HBNHAYAOSA-N 0.000 abstract 1
- 230000027758 ovulation cycle Effects 0.000 abstract 1
- 230000001817 pituitary effect Effects 0.000 abstract 1
- 239000000186 progesterone Substances 0.000 abstract 1
- 229960003387 progesterone Drugs 0.000 abstract 1
- 229940095055 progestogen systemic hormonal contraceptives Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESC040583 | 1967-04-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1253500A true GB1253500A (en) | 1971-11-17 |
Family
ID=7435756
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0714/71A Expired GB1253500A (en) | 1967-04-19 | 1968-04-19 | Method of contraception |
| GB1231412D Expired GB1231412A (cg-RX-API-DMAC7.html) | 1967-04-19 | 1968-04-19 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1231412D Expired GB1231412A (cg-RX-API-DMAC7.html) | 1967-04-19 | 1968-04-19 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3758687A (cg-RX-API-DMAC7.html) |
| BE (1) | BE713958A (cg-RX-API-DMAC7.html) |
| DE (1) | DE1617839A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR8061M (cg-RX-API-DMAC7.html) |
| GB (2) | GB1253500A (cg-RX-API-DMAC7.html) |
| NL (1) | NL6805612A (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4171358A (en) * | 1974-04-19 | 1979-10-16 | Eli Lilly And Company | Novel contraceptive method |
| US4018919A (en) * | 1975-07-16 | 1977-04-19 | Eli Lilly And Company | Sequential contraceptive method using two types of progestational agents |
| US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| US5433219A (en) * | 1992-09-23 | 1995-07-18 | Spery; Nanette S. | Receptive condom assembly |
| AUPQ291499A0 (en) * | 1999-09-17 | 1999-10-07 | Women's And Children's Hospital Adelaide | Novel nitro and sulphur containing compounds |
| US9844558B1 (en) | 2015-04-30 | 2017-12-19 | Amag Pharmaceuticals, Inc. | Methods of reducing risk of preterm birth |
| US10556922B2 (en) | 2015-09-29 | 2020-02-11 | Amag Pharmaceuticals, Inc. | Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate |
-
1967
- 1967-04-19 DE DE19671617839 patent/DE1617839A1/de active Pending
-
1968
- 1968-04-19 FR FR148725A patent/FR8061M/fr not_active Expired
- 1968-04-19 BE BE713958D patent/BE713958A/xx unknown
- 1968-04-19 GB GB0714/71A patent/GB1253500A/en not_active Expired
- 1968-04-19 GB GB1231412D patent/GB1231412A/en not_active Expired
- 1968-04-19 NL NL6805612A patent/NL6805612A/xx unknown
-
1971
- 1971-04-20 US US00135814A patent/US3758687A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB1231412A (cg-RX-API-DMAC7.html) | 1971-05-12 |
| FR8061M (cg-RX-API-DMAC7.html) | 1970-07-06 |
| DE1617839A1 (de) | 1971-04-08 |
| BE713958A (cg-RX-API-DMAC7.html) | 1968-10-21 |
| US3758687A (en) | 1973-09-11 |
| NL6805612A (cg-RX-API-DMAC7.html) | 1968-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4066757A (en) | Oral contraceptive regimen | |
| SE7416039L (cg-RX-API-DMAC7.html) | ||
| ATE114116T1 (de) | Kontinuierliche verabreichung des luteinisierendes hormon abgebenden hormons in kombination mit sexsteroidverabreichung als empfängnisverhütungsmittel. | |
| US3755573A (en) | Fertility control empoying quinestrol and quingestanol acetate | |
| DK365887D0 (da) | Kombinationsdoseringsform til hormonbehandling af kvinder i prae-menopausen | |
| Ulmann | Uses of RU 486 for contragestion: an update | |
| Kind et al. | Anti-ovulatory activity of subcutaneously injected steroids in the adult oestrus rabbit | |
| Glasier | Emergency contraception: time for de-regulation? | |
| Kurzrok | The prospects for hormonal sterilization | |
| GB1231412A (cg-RX-API-DMAC7.html) | ||
| GB1462893A (en) | Method for fertile breeding control in female bovine | |
| US4171358A (en) | Novel contraceptive method | |
| McPherson 3rd et al. | Effects of various progestational preparations on gonadotropin secretion in ovariectomized immature female rats | |
| Shearman | Oral contraceptive agents | |
| Howie | The progestogen-only pill | |
| GB1312760A (en) | Method of contraception | |
| Goldzieher | Symposium on steroid hormones. 1. Synthetic progestational steroids. Their significance and use | |
| Haspels | Post-coital oestrogen in large doses | |
| GB1214712A (en) | Contraceptive preparations | |
| Jeppsson | Background, development and properties of progestagens, with special reference to medroxyprogesterone acetate (MPA) | |
| Karim et al. | Injectable steroids as a method of contraception | |
| Swyer | Progestogens and their clinical uses: Part I | |
| Elstein | Low-dose progestagens as contraceptive agents | |
| Beaton | Menstrual regulation by sequential hormone therapy | |
| Greenblatt et al. | Estradiol pellet implantation for contraception |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |